What is Arise Bioscience?
Arise Bioscience operates as a prominent entity in the hemp-derived health and wellness sector, specializing in the manufacturing and distribution of high-quality cannabinoid-based products. The company occupies a critical niche, bridging the gap between raw agricultural production and consumer-facing wellness solutions. Through rigorous quality control and supply chain optimization, Arise Bioscience has established itself as a reliable partner for retailers and consumers seeking standardized, compliant hemp-based offerings. Its market position is defined by its ability to navigate complex regulatory environments while maintaining consistent product efficacy and brand integrity.
How much funding has Arise Bioscience raised?
Arise Bioscience has raised a total of $1.1M across 2 funding rounds:
Debt
$350K
Debt
$766K
Debt (2020): $350K with participation from PPP
Debt (2021): $766K led by PPP
Key Investors in Arise Bioscience
PPP
Public-Private Partnership
What's next for Arise Bioscience?
With the infusion of $766K, Arise Bioscience is well-positioned to accelerate its enterprise-level growth strategy. Future initiatives are expected to focus on the expansion of manufacturing capacity and the enhancement of distribution networks to meet rising consumer demand. As the regulatory landscape for hemp-derived products continues to evolve, the company is likely to prioritize investments in research and development to maintain its competitive edge. Furthermore, the strategic use of debt capital suggests a focus on sustainable, long-term asset acquisition and market penetration, ensuring that Arise Bioscience remains a dominant force in the wellness industry as it scales its operations to meet global market requirements.
See full Arise Bioscience company page
